52589-12-5: Digoxin EP Impurity E
Digoxin EP Impurity E (CAS No.: 52589-12-5) or Diginatin is a metabolite and is rarely hydrolyzable by beta-glucuronidase and by arylsulfatase and is a new cardiac glycoside from Digitalis lanata. Digoxin is a cardiac glycoside and is a medication used to treat various heart conditions. Most frequently it is used for atrial fibrillation, atrial flutter, and heart failure.
3β-[(2, 6-Dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2, 6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2, 6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-12β, 14, 16β-trihydroxy-5β-card-20(22)-enolide
"Europe PMC. “Europe PMC.” Europepmc.org, 2016, europepmc.org/article/med/7406600. ?Ehle, Michael, et al. “Digoxin: Clinical Highlights.” Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine, vol. 10, no. 2, June 2011, pp. 93–98, https://doi.org/10.1097/hpc.0b013e318221e7dd.?"